Royal Marsden Foundation Trust

London SW3 6JJ

1 studies enrolling now · 7 studies all time

What they study most

Advanced Epithelioid Sarcoma, Advanced Melanoma, Advanced Soft-tissue Sarcoma, Any Solid Tumor With an EZH2 GOF Mutation, Atypical Teratoid Rhabdoid Tumors (ATRT), Chronic Graft-versus-host-disease, Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Epithelioid Sarcoma, INI1-negative Tumors, Malignant Rhabdoid Tumor of Ovary, Malignant Rhabdoid Tumors (MRT)

Studies at this site

• A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) — Recruiting now
• Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL — Recruiting now
• A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment — Completed
• A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma — Running, not enrolling
• Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma — Stopped early
• A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma — Completed
• A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma — Stopped early